Postmenopausal hormone therapy and mortality before and after the Women’s Health Initiative study
We observed a diminished systemic HT prevalence and an elevated mortality danger for systemic HT end users in the two study populations in the wake of the 2002 WHI publication with the most pronounced inclination offered in the singleton populace. The conclusions suggest an alteration in the HT user profile just after 2002 with a unique pattern of HT use, most likely owing to the healthiest users determining to either fall systemic HT or switching to local HT, as tips…